HCA Healthcare, Inc. (HCA)

HCA Healthcare Stock Forecast

Stock Price Forecast

The 19 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $528, which forecasts a 3.40% increase in the stock price over the next year. The lowest target is $410 and the highest is $635.

Price Target: $528 (+3.40%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$410	$528	$546	$635
Change	-19.71%	+3.40%	+6.92%	+24.35%

* Price targets were last updated on Mar 10, 2026.

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	6	5	5	6	7	7
Buy	7	7	7	6	6	6
Hold	9	9	7	7	7	7
Sell	0	0	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	22	21	20	20	21	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Langston TD Cowen	TD Cowen	Strong Buy Maintains $529 → $561	Strong Buy	Maintains	$529 → $561	+9.86%	Mar 10, 2026
Ann Hynes Mizuho	Mizuho	Buy Maintains $540 → $585	Buy	Maintains	$540 → $585	+14.56%	Feb 25, 2026
Andrew Mok UBS	UBS	Strong Buy Maintains $598 → $635	Strong Buy	Maintains	$598 → $635	+24.35%	Feb 23, 2026
Benjamin Rossi JP Morgan	JP Morgan	Hold Maintains $420 → $535	Hold	Maintains	$420 → $535	+4.77%	Feb 20, 2026
David Toung Argus Research	Argus Research	Strong Buy Maintains $530 → $560	Strong Buy	Maintains	$530 → $560	+9.66%	Feb 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

79.43B

Increased by 5.07%

from 75.60B

Revenue Next Year

83.32B

Increased by 4.90%

from 79.43B

EPS This Year

30.53

Increased by 7.77%

from 28.33

EPS Next Year

33.67

Increased by 10.28%

from 30.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	58.75B	60.23B	64.97B	70.60B	75.60B	79.43B	83.32B
Revenue Growth	14.01%	2.52%	7.86%	8.67%	7.08%	5.07%	4.90%
EPS	21.16	19.15	18.97	22.00	28.33	30.53	33.67
EPS Growth	93.60%	-9.50%	-0.94%	15.97%	28.77%	7.77%	10.28%
Forward PE	-	-	-	-	-	16.73	15.17
No. Analysts	-	-	-	-	-	26	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	84.4B	89.3B
Avg	79.4B	83.3B
Low	75.5B	79.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	11.7%	12.5%
Avg	5.1%	4.9%
Low	-0.2%	-0.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	32.95	36.27
Avg	30.53	33.67
Low	28.52	31.45

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	16.3%	18.8%
Avg	7.8%	10.3%
Low	0.7%	3.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.